Revolutionary new test detects pancreatic cancer early
Scientists have developed a new blood test that could help detect pancreatic cancer at an early stage, potentially saving thousands of lives.
Pancreatic cancer is one of the most dangerous cancers and is known for being difficult to treat and diagnose, as only 10 percent of patients live more than 5 years after diagnosis, while more than half of them die within 3 months of diagnosis.
In a study conducted by scientists from the University of Pennsylvania and the Mayo Clinic, researchers tested different blood samples from people with and without pancreatic cancer.
In the study, the researchers focused on the CA19-9 and THBS2 markers used in medicine , and then discovered two new proteins in the blood called ANPEP and PIGR, according to the British newspaper “Daily Mail”.
It was found that the levels of these two proteins were higher in people with early-stage pancreatic cancer compared to healthy people.
When the team combined the four markers (CA19-9, THBS2, ANPEP, and PIGR) into a single test, they were able to identify pancreatic cancer with an accuracy of about 92 percent, according to the study published in the AACR medical journal.
The test also produced a false positive in only 5 percent of people without cancer. However, in cases of early-stage cancer, it was able to detect approximately 8 percent of cases.
References
Revolutionary new test detects pancreatic cancer early, sky news arabia, www.skynewsarabia.com/technology/1850591-اختبار-ثوري-جديد-يكشف-مبكرا-سرطان-البنكرياس
